open access
Double transformation of relapsing juvenile myelomonocytic leukemia to refractory acute myeloid leukemia
, 2, 2, 2, 2
Affiliations- Student Scientific Society, Collegium Medicum, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland
- Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University in Toruń, Jurasz University Hospital 1, Bydgoszcz, Poland
open access
Abstract
Abstract
Keywords
juvenile myelomonocytic leukemia, acute myeloid leukemia, transformation; relapse
Supp./Additional Files (1)
About this articleTitle
Double transformation of relapsing juvenile myelomonocytic leukemia to refractory acute myeloid leukemia
Journal
Issue
Article type
Clinical vignette
Pages
295-297
Published online
2022-08-04
Page views
3655
Article views/downloads
306
DOI
10.5603/AHP.a2022.0038
Bibliographic record
Acta Haematol Pol 2022;53(4):295-297.
Keywords
juvenile myelomonocytic leukemia
acute myeloid leukemia
transformation
relapse
Authors
Tomasz Styczyński
Jagoda Sadlok
Monika Richert-Przygońska
Robert Dębski
Małgorzata Kubicka
Beata Kuryło-Rafińska
Krzysztof Czyżewski
References (7)- Lasho T, Patnaik MM. Juvenile myelomonocytic leukemia — a bona fide RASopathy syndrome. Best Pract Res Clin Haematol. 2020; 33(2): 101171.
- Mayerhofer C, Niemeyer C, Flotho C. Current treatment of juvenile myelomonocytic lLeukemia. J Clin Med. 2021; 10(14): 3084.
- Gupta AK, Meena JP, Chopra A, et al. Juvenile myelomonocytic leukemia — a comprehensive review and recent advances in management. Am J Blood Res. 2021; 11(1): 1–21.
- Niemeyer CM. JMML genomics and decisions. Hematology Am Soc Hematol Educ Program. 2018; 2018(1): 307–312.
- Niemeyer CM, Flotho C. Juvenile myelomonocytic leukemia: who's the driver at the wheel? Blood. 2019; 133(10): 1060–1070.
- Chen S, Li F, Xu D, et al. The function of RAS mutation in cancer and advances in its drug research. Curr Pharm Des. 2019; 25(10): 1105–1114.
- Schönung M, Meyer J, Nöllke P, et al. International consensus definition of DNA methylation subgroups in juvenile myelomonocytic leukemia. Clin Cancer Res. 2021; 27(1): 158–168.